Biogen (BIIB) Tax Provisions (2009 - 2026)

Biogen (BIIB) has reported Tax Provisions for 18 consecutive years, with $58.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Tax Provisions fell 17.68% year-over-year to $58.2 million; the TTM figure through Mar 2026 stood at $251.1 million (down 8.06% YoY), while the FY2025 annual figure was $263.6 million, down 3.73% from the prior year.
• Tax Provisions came in at $58.2 million for Q1 2026 at Biogen, up from -$7.1 million in the prior quarter.
• The five-year high for Tax Provisions was $236.2 million in Q3 2022, with the low at -$72.9 million in Q3 2023.
• Average Tax Provisions over 5 years is $80.2 million, with a median of $70.7 million recorded in 2025.
• Across the five-year window, Tax Provisions jumped 1011.97% in 2022 and plunged 130.86% in 2023, its largest moves.
• Year by year, Tax Provisions stood at $54.3 million in 2022, then dropped by 21.36% to $42.7 million in 2023, then slumped by 41.92% to $24.8 million in 2024, then slumped by 128.63% to -$7.1 million in 2025, then surged by 919.72% to $58.2 million in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $58.2 million, -$7.1 million, and $90.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.